Over the last 50 years, billions of vaccines have been administered to prevent disease. Globally, immunizations prevent 2-3 million deaths annually from diseases like tetanus, pertussis, influenza, and measles. In 2019, the WHO reported that 86% of infants worldwide received three doses of diphtheria, tetanus, and pertussis vaccinations.
Since the onset of the COVID-19 pandemic, vaccination development has become a global point of focus. And while the development of the COVID-19 vaccinations occurred at a faster pace than traditionally seen, this development is still held to the same standards as other vaccinations. AdisInsight can help you keep up with the rapid pace of vaccine development within infectious disease. It is an integrated database of profiles authored by Springer Nature editors sourced from publicly available information from journals, conferences, trial registries, media releases, company websites, and government filings about pharmaceutical development programs, clinical trial studies, and published individual case safety reports. Information in AdisInsight is updated daily to keep you informed of the latest information impacting your research. Start searching on AdisInsight.
